Will Coca-Cola (KO) Expand Its Market Dominance With the Return of a Favorite Flavor?
Confident Investing Starts Here:
The reports don't claim when this return will happen, but do note that Diet Cherry Coke will only be around for a limited time. Leaks show a retro-inspired can and packaging for the promotion.
Coca-Cola fans have called on the company to revive Diet Cherry Coke after it was discontinued five years ago. The company has instead focused on its Coke Zero Sugar line of drinks, but sales of those still fall behind their Diet Coke variants. With that in mind, it makes sense that Coca-Cola would bring back a classic flavor to meet the demand for its diet drinks.
Coca-Cola Stock Analyst Coverage
In related news, there's new analyst coverage of KO stock that will please shareholders. Five-star Morgan Stanley analyst Dara Mohsenian reiterated a Buy rating and $81 price target for Coca-Cola stock, implying a 13.3% upside for the shares.
KO stock was also up 0.28% as of Monday afternoon. While not a major increase, baby steps to giant strides have resulted in a 15.78% rise year-to-date. This has resulted in the stock outperforming the major indices even in light of inflation, tariffs, and other economic headwinds.
Is Coca-Cola Stock a Buy, Sell, or Hold?
Turning to Wall Street, the analysts' consensus rating for Coca-Cola is Strong Buy, based on 14 Buy and one Hold rating over the past three months. With that comes an average KO stock price target of $79.50, representing a potential 11.09% upside for the shares.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Hewlett Packard Enterprise Stock Gets Morgan Stanley Upgrade on AI Spending Boom
Key Takeaways Hewlett Packard Enterprise shares gained when Morgan Stanley upgraded the stock from equal-weight to overweight. The analysts also increased the price target by $6 to $28. Morgan Stanley pointed to "healthy enterprise spending" for anything artificial intelligence- and network-related. Hewlett Packard Enterprise (HPE) shares advanced Thursday on an upgrade by Morgan Stanley, which sees increased corporate spending on the computer processing hardware maker's artificial intelligence (AI) and other products. Morgan Stanley raised its rating to "overweight" from "equal-weight," and boosted the price target to $28 from $22. In a note to clients, the analysts noted that "our checks signaled healthy enterprise spending across the board in the quarter, led by anything AI compute or networking related, followed by client devices (strong PC refresh), and then servers/storage, with networking growth inflecting positively for the first time in several quarters." They added that their research "leaves us positive on the potential for top and bottom line outperformance in the July quarter across the group." Along with the Hewlett Packard Enterprise moves, Morgan Stanley also increased the price targets for Dell Technologies (DELL) and NetApp (NTAP). With today's gains of more than 3%, shares of Hewlett Packard Enterprise moved into positive territory this year. Read the original article on Investopedia
Yahoo
3 hours ago
- Yahoo
CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The 5 Upgrades: Morgan Stanley upgraded HP Enterprise (HPE) to Overweight from Equal Weight with a price target of $28, up from $22. The firm believes accretion from the Juniper acquisition and multiple upside is not being priced into the shares. H.C. Wainwright upgraded CoreWeave (CRWV) to Buy from Neutral with an $180 price target. The stock's valuation "has sunk deep enough," the analyst tells investors in a research note. Arete also upgraded CoreWeave to Buy from Neutral with an $180 price target. Citi upgraded Bio-Techne (TECH) to Buy from Neutral with a price target of $70, up from $55. The firm views the company's growth and margin outlook as conservative and believes the stock is undervalued at current levels. Jefferies upgraded Enphase Energy (ENPH) to Hold from Underperform with a price target of $36, up from $28. Treasury guidance issued on Friday of last week was positive for residential solar, yet Enphase's stock is up just about 10%, notes the analyst, who perceives a market disconnect in which the buyside gives little credit for TPO sales, wrongly assuming the majority of sales are tied instead to cash/loan. UBS upgraded iQiyi (IQ) to Buy from Neutral with a price target of $3.32, up from $1.97. iQiyi's fundamentals could be bottoming out amid a more benign regulatory environment, the analyst tells investors in a research 5 Downgrades: Wedbush downgraded Instacart (CART) to Underperform from Neutral with a price target of $42, down from $55, arguing that Amazon's (AMZN) expansion of its same-day perishable grocery delivery service has intensified competition. Citi downgraded Coty (COTY) to Neutral from Buy with a price target of $4.25, down from $6.50. The company's fiscal Q4 results came in weaker than expected despite a low bar, the analyst tells investors in a research note. Wells Fargo downgraded Truist Financial (TFC) to Equal Weight from Overweight with an unchanged $47 price target after its announced 5-year strategic plan that contains "new new metrics." The company is lagging its numerous peers with this announcement after years of share loss and weak JD Power rankings, the analyst tells investors in a research note. JPMorgan downgraded Alcon (ALC) to Neutral from Overweight with a price target of $77.53, down from $105.88. The company reported another "soft" quarter and cut to guidance, the analyst tells investors in a research note. BofA downgraded (MNDY) to Neutral from Buy with a price target of $205, down from $240. Search engine optimization driven website visits to sank by an average of 23.5% year-over-year in Q2 and declines accelerated to 25.3% in July, according to Similarweb data, reports the analyst. Top 5 Initiations: Argus initiated coverage of DexCom (DXCM) with a Buy rating and $100 price target. The firm sees the company maintaining above industry average growth with expanding customer reach across the continuous glucose monitoring for diabetes landscape and leveraging costs to enhance profitability. Morgan Stanley assumed coverage of NetApp (NTAP) with an Equal Weight rating and price target of $115, up from $106. The firm says its intra-quarter storage channel checks were most cautious for NetApp. Rosenblatt initiated coverage of PubMatic (PUBM) with a Buy rating and $17 price target. The company's Q2 earnings report unearthed a second problem in a major DSP relationship, setting the stage for a decline in adjusted EBITDA in 2026, but these operating challenges seem likely to be overcome, the analyst tells investors in a research note. BofA initiated coverage of NuScale Power (SMR) with a Neutral rating and $36 price target. The developer of small modular reactor nuclear technology's use of lightwater technology and LEU, rather than scarce HALEU, offers "a more de-risked fuel pathway" than peers, but the firm's Neutral rating reflects the early commercialization stage, a lack of binding contracts, and a valuation that "already prices in significant future success." Morgan Stanley initiated coverage of Trevi Therapeutics (TRVI) with an Overweight rating and $18 price target. The firm sees a multi-billion dollar opportunity for Haduvio. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
4 hours ago
- Yahoo
Why is the stock market so resilient to policy risks
-- The S&P 500 has remained resilient despite weakening macroeconomic data, according to Morgan Stanley analysts, who argue that the key lies in sector-specific impacts of policy choices. 'The economy and markets have been telling diverging stories: macroeconomic data point to an incrementally weakening environment, while the S&P 500 has posted positive YTD performance after April's significant low,' Morgan Stanley said. The bank explained that tariffs and immigration have created macroeconomic headwinds, dragging on growth and inflation. However, the negative effects are concentrated in sectors with a limited share of the index's market capitalization. By contrast, 'the OBBBA benefits sectors with large weights in the index due to provisions like upfront R&D expensing and bonus depreciation. These create cash flow benefits for sectors with an outsized share of market cap,' Morgan Stanley noted. The firm stressed that equity markets are forward-looking, having already priced in a slowdown earlier this year. 'Liberation Day marked peak uncertainty and peak concern around tariffs for equity investors, and we believe the market is now focused on a rebounding earnings backdrop,' the analysts wrote. From a sectoral perspective, Consumer Discretionary faces 'a combination of margin pressure and weaker pricing power,' leading to underperformance. Industrials are seen benefiting from near-shoring and domestic AI investment, while semiconductors have outperformed thanks to the AI theme despite policy headwinds. Morgan Stanley said this explains why U.S. equities have held up. The firm remains overweight Industrials and Financials, while underweight Consumer Discretionary, expecting continued strength in 'AI/Tech Diffusion and Re-shoring themes within the U.S.' Related articles Why is the stock market so resilient to policy risks Tesla: Hype Aside, How Much Is the EV Giant Really Worth Now? If Powell goes, does Fed trust go with him? Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
